RhumbLine Advisers’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-38,693
| Closed | -$184K | – | 3261 |
|
|
2022
Q1 | $184K | Buy |
38,693
+3,497
| +10% | +$16.6K | ﹤0.01% | 2777 |
|
|
2021
Q4 | $128K | Sell |
35,196
-780
| -2% | -$2.84K | ﹤0.01% | 2909 |
|
|
2021
Q3 | $289K | Buy |
35,976
+5,894
| +20% | +$47.3K | ﹤0.01% | 2783 |
|
|
2021
Q2 | $341K | Buy |
+30,082
| New | +$341K | ﹤0.01% | 2735 |
|
|
2015
Q2 | – | Sell |
-240
| Closed | -$124K | – | 3097 |
|
|
2015
Q1 | $124K | Buy |
240
+44
| +22% | +$22.7K | ﹤0.01% | 2928 |
|
|
2014
Q4 | $105K | Buy |
196
+11
| +6% | +$5.89K | ﹤0.01% | 2954 |
|
|
2014
Q3 | $277K | Hold |
185
| – | – | ﹤0.01% | 2575 |
|
|
2014
Q2 | $253K | Buy |
185
+54
| +41% | +$73.8K | ﹤0.01% | 2698 |
|
|
2014
Q1 | $182K | Sell |
131
-8
| -6% | -$11.1K | ﹤0.01% | 2805 |
|
|
2013
Q4 | $138K | Sell |
139
-5
| -3% | -$4.96K | ﹤0.01% | 2919 |
|
|
2013
Q3 | $150K | Buy |
144
+4
| +3% | +$4.17K | ﹤0.01% | 2866 |
|
|
2013
Q2 | $154K | Buy |
+140
| New | +$154K | ﹤0.01% | 3109 |
|